Literature DB >> 16203156

Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.

Patricia Soo-Ping Thong1, Frank Watt, Min Qin Ren, Puay Hoon Tan, Khee Chee Soo, Malini Olivo.   

Abstract

Photodynamic therapy (PDT) outcome depends on the conditions under which it is carried out. Maintaining the tumour tissue oxygen level is important for PDT efficacy and using a low fluence rate can improve outcome. In this work we studied the response of human nasopharyngeal carcinoma tumours in murine models to hypericin-PDT carried out under low fluence and fluence rate. A drug-light interval (DLI) of 1h or 6h was used for 1h-PDT and 6h-PDT, respectively. Evan's blue test was used to assess necrosis and TUNEL staining for apoptosis. Nuclear microscopy was used to quantify elemental concentrations in tumours. Serum vascular endothelial growth factor (VEGF) levels were also determined. TUNEL results showed that 6h-PDT induced significantly more apoptosis compared to 1h-PDT (p<0.01). This was supported by nuclear microscopy showing an increase in calcium and a decrease in zinc levels (both known triggers of apoptosis) in 6h-PDT tumours compared to non-PDT tumours (p<0.05). These results further imply a zinc-mediated pathway in hypericin-PDT induced apoptosis. 6h-PDT also resulted in a significant increase in copper concentrations compared to non-PDT tumours (p<0.05). Serum VEGF levels measured after 6h-PDT were lower than those obtained after 1h-PDT. Overall tumour response to hypericin-PDT under low fluence and fluence rate and using a 6h DLI showed increased apoptosis and lower serum VEGF levels. This treatment regime is suitable for the alternative approach of multi-fraction PDT in which the tumour can be exposed to multiple PDT fractions for complete tumour response. This alternative approach might yield improved outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16203156     DOI: 10.1016/j.jphotobiol.2005.08.002

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  7 in total

1.  Photodynamic therapy-induced angiogenic signaling: consequences and solutions to improve therapeutic response.

Authors:  Shannon M Gallagher-Colombo; Amanda L Maas; Min Yuan; Theresa M Busch
Journal:  Isr J Chem       Date:  2012-09-01       Impact factor: 3.333

2.  Mono- and tri-cationic porphyrin-monoclonal antibody conjugates: photodynamic activity and mechanism of action.

Authors:  Karen Smith; Nela Malatesti; Nicole Cauchon; Darel Hunting; Roger Lecomte; Johan E van Lier; John Greenman; Ross W Boyle
Journal:  Immunology       Date:  2010-10-29       Impact factor: 7.397

3.  Photodynamic therapy and tumor imaging of hypericin-treated squamous cell carcinoma.

Authors:  Christian S Head; Quang Luu; Joel Sercarz; Romaine Saxton
Journal:  World J Surg Oncol       Date:  2006-12-05       Impact factor: 2.754

Review 4.  Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities.

Authors:  Malini Olivo; Ramaswamy Bhuvaneswari; Sasidharan Swarnalatha Lucky; Nagamani Dendukuri; Patricia Soo-Ping Thong
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-14

5.  Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane.

Authors:  Martin Majerník; Rastislav Jendželovský; Marián Babinčák; Ján Košuth; Juraj Ševc; Zuzana Tonelli Gombalová; Zuzana Jendželovská; Monika Buríková; Peter Fedoročko
Journal:  Int J Mol Sci       Date:  2019-06-19       Impact factor: 5.923

6.  The Influence of Hypericin-Mediated Photodynamic Therapy on Interleukin-8 and -10 Secretion in Colon Cancer Cells.

Authors:  Marta Kaleta-Richter; David Aebisher; Dagmara Jaworska; Zenon Czuba; Grzegorz Cieślar; Aleksandra Kawczyk-Krupka
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

Review 7.  Hypericin in the Light and in the Dark: Two Sides of the Same Coin.

Authors:  Zuzana Jendželovská; Rastislav Jendželovský; Barbora Kuchárová; Peter Fedoročko
Journal:  Front Plant Sci       Date:  2016-05-06       Impact factor: 5.753

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.